Inhibition of HCV RNA-dependent RNA polymerase activity by aqueous extract from Fructus Ligustri Lucidi (Q40127401)

17 September 2017

title

Inhibition of HCV RNA-dependent RNA polymerase activity by aqueous extract from Fructus Ligustri Lucidi (English)

1 reference

17 September 2017

Lingbao Kong

1 reference

17 September 2017

Shanshan Li

1 reference

17 September 2017

Xue Han

1 reference

17 September 2017

Zhonghua Xiang

1 reference

17 September 2017

Xiaonan Fang

1 reference

17 September 2017

Baozong Li

1 reference

17 September 2017

Wei Wang

1 reference

17 September 2017

Hong Zhong

1 reference

17 September 2017

Jingrong Gao

1 reference

17 September 2017

Linbai Ye

1 reference

17 September 2017

publication date

24 May 2007

1 reference

17 September 2017

1 reference

17 September 2017

volume

128

1 reference

17 September 2017

issue

1-2

1 reference

17 September 2017

page(s)

9-17

1 reference

In vitro antiviral activity of a saponin from Anagallis arvensis, Primulaceae, against herpes simplex virus and poliovirus

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

Natural product drug discovery and development: new perspectives on international collaboration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

A critical role for the chimpanzee model in the study of hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

Inhibition of hepatitis C virus RNA replication by 2'-modified nucleoside analogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

Inhibition of growth of human immunodeficiency virus in vitro by crude extracts of Chinese medicinal herbs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

Challenges and successes in developing new therapies for hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

The challenge of developing a vaccine against hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

Genetic Analysis of Sequences in the 3' Nontranslated Region of Hepatitis C Virus That Are Important for RNA Replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

Sequences in the 5' nontranslated region of hepatitis C virus required for RNA replication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

Cellular RNA helicase p68 relocalization and interaction with the hepatitis C virus (HCV) NS5B protein and the potential role of p68 in HCV RNA replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

Plant photosensitizers with antiviral properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

Protein kinase C-related kinase 2 regulates hepatitis C virus RNA polymerase function by phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

Establishment of stable HeLa cell lines expressing enzymatically active hepatitis C virus RNA polymerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

Human eukaryotic initiation factor 4AII associates with hepatitis C virus NS5B protein in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

Complete replication of hepatitis C virus in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

Unravelling hepatitis C virus replication from genome to function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

Natural history of hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

Effect of hepatitis C virus (HCV) NS5B-nucleolin interaction on HCV replication with HCV subgenomic replicon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

Isolation, purification, and partial characterization of prunellin, an anti-HIV component from aqueous extracts of Prunella vulgaris.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses: in vitro and in vivo studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

In vivo analysis of the 3' untranslated region of the hepatitis C virus after in vitro mutagenesis of an infectious cDNA clone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

Mechanism of inhibition of HIV-1 infection in vitro by purified extract of Prunella vulgaris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

3' nontranslated RNA signals required for replication of hepatitis C virus RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

Extremely low frequency (ELF) pulsed-gradient magnetic fields inhibit malignant tumour growth at different biological levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

Robust hepatitis C virus infection in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.03.020

10.1016/J.VIRUSRES.2007.03.020

7 January 2021

Identifiers

DOI

1 reference

17 September 2017

1 reference